Lidocaine hydrochloride

✨ ‌Lidocaine Hydrochloride (CAS 73-78-9) | Pharmaceutical-Grade Local Anesthetic & Antiarrhythmic Agent‌ ✨

🧪 ‌Product Overview‌

‌Lidocaine Hydrochloride‌ (CAS 73-78-9) is a widely used ‌amide-class local anesthetic‌ and ‌antiarrhythmic drug‌ with the molecular formula ‌C₁₄H₂₂N₂O·HCl‌ and a molecular weight of ‌270.80‌. This white crystalline powder (purity ≥99%) is essential for pain management in clinical settings and serves as a critical intermediate in pharmaceutical manufacturing. It provides rapid, reversible nerve blockade and stabilizes cardiac membranes in arrhythmia treatment.

‌Key Functions‌:

• Induces local anesthesia for surgical and diagnostic procedures.

• Reduces ventricular arrhythmias in emergency care.

• Acts as a reference standard in drug quality control.

‌Target Industries‌: Pharmaceuticals, hospitals, and research laboratories.

⭐ ‌Key Advantages‌

🏭 ‌Applications‌

• ‌Local Anesthesia‌

  : Topical creams, sprays, and injectables for minor surgeries.

• ‌Cardiac Care‌

  : Intravenous administration for arrhythmia control.

• ‌Pharmaceutical R&D‌

  : Impurity profiling and API synthesis.

📊 ‌Quality Assurance‌

• ‌Testing Standards‌

  : Complies with 

  ‌USP/EP‌

   pharmacopeial requirements.

• ‌Analytical Methods‌

  : HPLC, NMR, and mass spectrometry validation.

• ‌Certifications‌

  : ISO 9001 and GMP compliance for pharmaceutical use.

📈 ‌Market Insights‌

The global local anesthetics market is projected to grow at ‌6.1% CAGR (2025–2030)‌, driven by rising surgical volumes and demand for minimally invasive therapies. Lidocaine remains a cornerstone in emergency medicine, with Asia-Pacific emerging as a key growth region due to expanding healthcare access.